ArticleJournal of cancer research and clinical oncology2023

Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation.

Franz-Josef Wischmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.